<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26657027</PMID><DateCompleted><Year>2016</Year><Month>10</Month><Day>13</Day></DateCompleted><DateRevised><Year>2019</Year><Month>12</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>5</Volume><PubDate><Year>2015</Year><Month>Dec</Month><Day>11</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Infectious dengue vesicles derived from CD61+ cells in acute patient plasma exhibited a diaphanous appearance.</ArticleTitle><Pagination><StartPage>17990</StartPage><MedlinePgn>17990</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">17990</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/srep17990</ELocationID><Abstract><AbstractText>The levels of neutralizing antibody to a pathogen are an effective indicator to predict efficacy of a vaccine in trial. And yet not all the trial vaccines are in line with the theory. Using dengue virus (DENV) to investigate the viral morphology affecting the predictive value, we evaluated the viral morphology in acute dengue plasma compared to that of Vero cells derived DENV. The virions in plasma were infectious and heterogeneous in shape with a "sunny-side up egg" appearance, viral RNA was enclosed with CD61+ cell-derived membrane interspersed by the viral envelope protein, defined as dengue vesicles. The unique viral features were also observed from ex vivo infected human bone marrow. Dengue vesicles were less efficiently neutralized by convalescent patient serum, compared to virions produced from Vero cells. Our results exhibit a reason why potencies of protective immunity fail in vivo and significantly impact dengue vaccine and drug development.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hsu</LastName><ForeName>Alan Yi-Hui</ForeName><Initials>AY</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Tainan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Basic Medical Sciences, College of Medicine, Tainan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center of Infectious Disease and Signaling Research, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Shang-Rung</ForeName><Initials>SR</Initials><AffiliationInfo><Affiliation>Institute of Oral Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsai</LastName><ForeName>Jih-Jin</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Tropical Medicine Center, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, School of Medicine, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Dengue Fever Control and Research, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Po-Lin</ForeName><Initials>PL</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Ya-Ping</ForeName><Initials>YP</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Tsai-Yun</ForeName><Initials>TY</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lo</LastName><ForeName>Yu-Chih</ForeName><Initials>YC</Initials><AffiliationInfo><Affiliation>Center of Infectious Disease and Signaling Research, Tainan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Bioinformatics and Biosignal Transduction, College of Bioscience and Biotechnology, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ho</LastName><ForeName>Tzu-Chuan</ForeName><Initials>TC</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Tainan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Basic Medical Sciences, College of Medicine, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Meed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Min-Ting</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>Institute of Oral Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chiu</LastName><ForeName>Yen-Chi</ForeName><Initials>YC</Initials><AffiliationInfo><Affiliation>Institute of Oral Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perng</LastName><ForeName>Guey Chuen</ForeName><Initials>GC</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Tainan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Basic Medical Sciences, College of Medicine, Tainan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center of Infectious Disease and Signaling Research, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>12</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D036022">Capsid Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D039661">Integrin beta3</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001692" MajorTopicYN="N">Biological Transport</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001854" MajorTopicYN="N">Bone Marrow Cells</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D036022" MajorTopicYN="N">Capsid Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002462" MajorTopicYN="N">Cell Membrane</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002522" MajorTopicYN="N">Chlorocebus aethiops</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D022162" MajorTopicYN="N">Cytoplasmic Vesicles</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003715" MajorTopicYN="N">Dengue</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003716" MajorTopicYN="N">Dengue Virus</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName><QualifierName UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D039661" MajorTopicYN="N">Integrin beta3</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008533" MajorTopicYN="N">Megakaryocytes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065288" MajorTopicYN="N">Serogroup</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014709" MajorTopicYN="N">Vero Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019562" MajorTopicYN="N">Viral Load</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014771" MajorTopicYN="N">Virion</DescriptorName><QualifierName UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>7</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>11</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>10</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26657027</ArticleId><ArticleId IdType="pmc">PMC4675971</ArticleId><ArticleId IdType="doi">10.1038/srep17990</ArticleId><ArticleId IdType="pii">srep17990</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Capeding M. R. et al. Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial. Lancet, 384(9951), 1358&#x2013;1365, 10.1016/S0140-6736(14)61060-6 (2014).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(14)61060-6</ArticleId><ArticleId IdType="pubmed">25018116</ArticleId></ArticleIdList></Reference><Reference><Citation>Villar L. et al. Efficacy of a tetravalent dengue vaccine in children in Latin America. N Engl J Med 372, 113&#x2013;123, 10.1056/NEJMoa1411037 (2015).</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1411037</ArticleId><ArticleId IdType="pubmed">25365753</ArticleId></ArticleIdList></Reference><Reference><Citation>Sirivichayakul C., Sabchareon A., Limkittikul K. &amp; Yoksan S. Plaque reduction neutralization antibody test does not accurately predict protection against dengue infection in Ratchaburi cohort, Thailand. Virol J 11, 48, 10.1186/1743-422X-11-48 (2014).</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-11-48</ArticleId><ArticleId IdType="pmc">PMC3975240</ArticleId><ArticleId IdType="pubmed">24620925</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas S. J. &amp; Endy T. P. Current issues in dengue vaccination. Curr Opin Infect Dis 26, 429&#x2013;434, 10.1097/01.qco.0000433310.28771.cc (2013).</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.qco.0000433310.28771.cc</ArticleId><ArticleId IdType="pubmed">23963259</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabchareon A. et al. Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial. Lancet, 380(9853), 1559&#x2013;1567, 10.1016/S0140-6736(12)61428-7 (2012).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(12)61428-7</ArticleId><ArticleId IdType="pubmed">22975340</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO. Dengue guidelines for diagnosis, treatment, prevention and control. World Health Organization (2009) (Date of access: 09/10/2015). &lt;http://whqlibdoc.who.int/publications/2009/9789241547871_eng.pdf&gt;.</Citation></Reference><Reference><Citation>Tsai J.-J. et al. The importance of hematopoietic progenitor cells in dengue. Therapeutic Advances in Hematology 3, 59&#x2013;71, 10.1177/2040620711417660 (2012).</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2040620711417660</ArticleId><ArticleId IdType="pmc">PMC3573426</ArticleId><ArticleId IdType="pubmed">23556112</ArticleId></ArticleIdList></Reference><Reference><Citation>Gubler D. J. &amp; Kuno. G., Dengue and dengue hemorrhagic Fever. (CABI, Wallingford, UK, 1997).</Citation></Reference><Reference><Citation>Sabin A. B. Research on dengue during World War II. American journal of tropical Medicine and Hygiene 1, 30&#x2013;50 (1952).</Citation><ArticleIdList><ArticleId IdType="pubmed">14903434</ArticleId></ArticleIdList></Reference><Reference><Citation>Wahala W. M., Kraus A. A., Haymore L. B., Accavitti-Loper M. A. &amp; de Silva A. M. Dengue virus neutralization by human immune sera: role of envelope protein domain III-reactive antibody. Virology 392, 103&#x2013;113, S0042-6822(09)00388-210.1016/j.virol.2009.06.037 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2746956</ArticleId><ArticleId IdType="pubmed">19631955</ArticleId></ArticleIdList></Reference><Reference><Citation>Midgley C. M. et al. An in-depth analysis of original antigenic sin in dengue virus infection. J Virol 85, 410&#x2013;421, 10.1128/JVI.01826-10 (2011).</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01826-10</ArticleId><ArticleId IdType="pmc">PMC3014204</ArticleId><ArticleId IdType="pubmed">20980526</ArticleId></ArticleIdList></Reference><Reference><Citation>Hotta S. Therapeutic experiments on dengue infection in mice. Ann Trop Med Parasitol 47, 1&#x2013;8 (1953).</Citation><ArticleIdList><ArticleId IdType="pubmed">13041126</ArticleId></ArticleIdList></Reference><Reference><Citation>Bierman H. R. &amp; Nelson E. R. Hematodepressive Virus Diseases of Thailand. Ann Intern Med 62, 867&#x2013;884 (1965).</Citation><ArticleIdList><ArticleId IdType="pubmed">14283387</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark K. B. et al. Multiploid CD61+ cells are the pre-dominant cell lineage infected during acute dengue virus infection in bone marrow. PLoS One 7, e52902, 10.1371/journal.pone.0052902 (2012).</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0052902</ArticleId><ArticleId IdType="pmc">PMC3531377</ArticleId><ArticleId IdType="pubmed">23300812</ArticleId></ArticleIdList></Reference><Reference><Citation>Noisakran S. et al. Infection of bone marrow cells by dengue virus in vivo. Exp Hematol 40, 250&#x2013;259 e254, 10.1016/j.exphem.2011.11.011 (2012).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.exphem.2011.11.011</ArticleId><ArticleId IdType="pmc">PMC3415316</ArticleId><ArticleId IdType="pubmed">22193689</ArticleId></ArticleIdList></Reference><Reference><Citation>Noisakran S. et al. Role of CD61(+) cells in thrombocytopenia of dengue patients. Int J Hematol, 10.1007/s12185-012-1175-x (2012).</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12185-012-1175-x</ArticleId><ArticleId IdType="pmc">PMC3606877</ArticleId><ArticleId IdType="pubmed">22987294</ArticleId></ArticleIdList></Reference><Reference><Citation>Bray P. F. Dengue platelets meet Sir Arthur Conan Doyle. Blood 122, 3400&#x2013;3401, 10.1182/blood-2013-09-526418 (2013).</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2013-09-526418</ArticleId><ArticleId IdType="pubmed">24235131</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon A. Y., Sutherland M. R. &amp; Pryzdial E. L. Dengue virus binding and replication by platelets. Blood, 10.1182/blood-2014-09-598029 (2015).</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2014-09-598029</ArticleId><ArticleId IdType="pmc">PMC4826145</ArticleId><ArticleId IdType="pubmed">25943787</ArticleId></ArticleIdList></Reference><Reference><Citation>Gromowski G. D. &amp; Barrett A. D. Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus. Virology 366, 349&#x2013;360, 10.1016/j.virol.2007.05.042 (2007).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2007.05.042</ArticleId><ArticleId IdType="pubmed">17719070</ArticleId></ArticleIdList></Reference><Reference><Citation>Bargeron Clark K., Hsiao H. M., Noisakran S., Tsai J. J. &amp; Perng G. C. Role of microparticles in dengue virus infection and its impact on medical intervention strategies. Yale J Biol Med 85, 3&#x2013;18 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3313537</ArticleId><ArticleId IdType="pubmed">22461739</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinha G. Sanofi&#x2019;s dengue vaccine first to complete phase 3. Nature biotechnology 32, 605&#x2013;606, 10.1038/nbt0714-605a (2014).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt0714-605a</ArticleId><ArticleId IdType="pubmed">25004214</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith T. J., Brandt W. E., Swanson J. L., McCown J. M. &amp; Buescher E. L. Physical and biological properties of dengue-2 virus and associated antigens. J Virol 5, 524&#x2013;532 (1970).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC376035</ArticleId><ArticleId IdType="pubmed">4195055</ArticleId></ArticleIdList></Reference><Reference><Citation>Sriurairatna S., Bhamarapravati N. &amp; Phalavadhtana O. Dengue virus infection of mice: morphology and morphogenesis of dengue type-2 virus in suckling mouse neurones. Infect Immun 8, 1017&#x2013;1028 (1973).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC422964</ArticleId><ArticleId IdType="pubmed">4594115</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhn R. J. et al. Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell 108, 717&#x2013;725, S0092867402006608 (2002).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4152842</ArticleId><ArticleId IdType="pubmed">11893341</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodenhuis-Zybert I. A. et al. A fusion-loop antibody enhances the infectious properties of immature flavivirus particles. J Virol 85, 11800&#x2013;11808, JVI.05237-1110.1128/JVI.05237-11 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3209313</ArticleId><ArticleId IdType="pubmed">21880758</ArticleId></ArticleIdList></Reference><Reference><Citation>Junjhon J. et al. Differential modulation of prM cleavage, extracellular particle distribution, and virus infectivity by conserved residues at nonfurin consensus positions of the dengue virus pr-M junction. J Virol 82, 10776&#x2013;10791, JVI.01180-0810.1128/JVI.01180-08 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2573171</ArticleId><ArticleId IdType="pubmed">18715923</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X. et al. Dengue structure differs at the temperatures of its human and mosquito hosts. Proc Natl Acad Sci USA 110, 6795&#x2013;6799, 10.1073/pnas.1304300110 (2013).</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1304300110</ArticleId><ArticleId IdType="pmc">PMC3637732</ArticleId><ArticleId IdType="pubmed">23569243</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaichana P. et al. Low levels of antibody-dependent enhancement in vitro using viruses and plasma from dengue patients. PLoS One 9, e92173, 10.1371/journal.pone.0092173 (2014).</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0092173</ArticleId><ArticleId IdType="pmc">PMC3958444</ArticleId><ArticleId IdType="pubmed">24642752</ArticleId></ArticleIdList></Reference><Reference><Citation>Dejnirattisai W. et al. Cross-reacting antibodies enhance dengue virus infection in humans. Science 328, 745&#x2013;748, 328/5979/74510.1126/science.1185181 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3837288</ArticleId><ArticleId IdType="pubmed">20448183</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothman A. L. Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms. Nat Rev Immunol 11, 532&#x2013;543, nri301410.1038/nri3014 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21760609</ArticleId></ArticleIdList></Reference><Reference><Citation>Young N. S. Flaviviruses and bone marrow failure. JAMA 263, 3065&#x2013;3068 (1990).</Citation><ArticleIdList><ArticleId IdType="pubmed">2160551</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito K. &amp; Suda T. Metabolic requirements for the maintenance of self-renewing stem cells. Nature reviews. Molecular cell biology 15, 243&#x2013;256, 10.1038/nrm3772 (2014).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm3772</ArticleId><ArticleId IdType="pmc">PMC4095859</ArticleId><ArticleId IdType="pubmed">24651542</ArticleId></ArticleIdList></Reference><Reference><Citation>Lioznov M. V., Freiberger P., Kroger N., Zander A. R. &amp; Fehse B. Aldehyde dehydrogenase activity as a marker for the quality of hematopoietic stem cell transplants. Bone marrow transplantation 35, 909&#x2013;914, 10.1038/sj.bmt.1704928 (2005).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.bmt.1704928</ArticleId><ArticleId IdType="pubmed">15765109</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernandez R., Brown D. T. &amp; Paredes A. Structural differences observed in arboviruses of the alphavirus and flavivirus genera. Adv Virol 2014, 259382, 10.1155/2014/259382 (2014).</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/259382</ArticleId><ArticleId IdType="pmc">PMC4182009</ArticleId><ArticleId IdType="pubmed">25309597</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO. Guidelines for plaque reduction neutralization testing of human antibodies to dengue viruses. World Health Organization (2007) (Date of access:09/10/2015) &lt;http://apps.who.int/iris/bitstream/10665/69687/1/who_ivb_07.07_eng.pdf&gt;.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>